Pfizer-BioNTech Covid-19 vaccine(AP Photo/Ginnette Riquelme)
A study involving a group of doctors who have received different vaccines against Covid-19 showed that the three vaccines administered in Serbia had been very successful in terms of the production of antibodies, says a representative of the Serbian Institute for Nuclear Energy Use, Marija Gnjatovic.
In an interview with the Serbian Broadcasting Corporation (RTS) she recommended that the recipients who wished to check their antibody status after vaccinations should wait at least two weeks after the second dose, explaining that the speed at which antibodies develop depended on the vaccine.
According to Gnjatovic, the recipients of China's Sinopharm vaccine have been the slowest to churn up antibodies, but they are expected to last the longest. She has warned again that "people can get infected between doses," appealing that all restrictions should be respected "until it's proved that vaccinated persons can't transmit the virus."
To get full access to all content of interest see our
Subscription offer
Or
Register for free
And read up to 5 articles each month.
Already have an account? Please Log in.